Background: Pediatric heart transplant recipients are at risk for increased left ventricular (LV) diastolic stiffness. However, the noninvasive evaluation of LV stiffness has remained elusive in this population. The objective of this study was to compare novel echocardiographic measures of LV diastolic stiffness versus gold-standard measures derived from pressure-volume loop (PVL) analysis in pediatric heart transplant recipients.
Results: Of 24 children, 18 were heart transplant recipients. Six control patients had hemodynamically insignificant patent ductus arteriosus or coronary fistula. The mean age was 9.1 6 5.6 years. Median end-diastolic pressure was 9 mm Hg (interquartile range, 8-13 mm Hg). Lateral E:e 0 /EDV (r = 0.59, P < .01), septal E:e 0 /EDV (r = 0.57, P < .01), and (E:circumferential early diastolic strain rate)/EDV (r = 0.54, P < .01) correlated with b. Lateral E:e 0 /EDV displayed a C statistic of 0.93 in detecting patients with abnormal LV stiffness (b > 0.015 mL À1 ). A lateral E:e 0 /EDV of >0.15 mL À1 had 89% sensitivity and 93% specificity in detecting an abnormal b.
Conclusions: Echocardiographic estimates of ventricular stiffness may be accurate compared with the gold standard in pediatric heart transplant recipients. The clinical usefulness of these noninvasive measures in assessing LV stiffness merits further study in children. (J Am Soc Echocardiogr 2018;31:342-8.)
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Patients who have undergone heart transplantation are known to be at risk for increased ventricular stiffness due to prolonged ischemic time, donor-recipient size mismatch, and/or a history of rejection. [1] [2] [3] Even in the presence of preserved ejection fraction, increased ventricular stiffness results in heart failure symptoms, exercise intolerance, decreased quality of life, and increased risk for mortality. [4] [5] [6] However, the importance of ventricular stiffness in pediatric heart transplant recipients is unknown because of the challenges in the noninvasive assessment of diastolic function, specifically, in the noninvasive assessment of ventricular stiffness. Currently, the invasive evaluation of the end-diastolic pressure-volume relationship derived from pressure-volume loop (PVL) analysis is the reference standard method used to assess ventricular stiffness. 7, 8 However, PVL analysis is rarely performed for clinical purposes in children, because of the required invasive procedures and load alteration.
Current echocardiographic assessment of left ventricular (LV) diastolic function has focused on early active relaxation/diastolic suction (spectral Doppler mitral E and tissue Doppler e 0 velocities, isovolumic relaxation time, etc) and the estimation of filling pressures (lateral and septal E:e 0 ). 9 These measures have been well validated against the reference standard in both adults and children. [10] [11] [12] [13] Although the assessment of filling pressures is an often used marker of diastolic function, it has limitations. Filling pressures are influenced by loading conditions, myocardial elastic properties, and pericardial properties. In addition, changes in ventricular stiffness often occur before an elevation in filling, making it an insensitive marker of early diastolic dysfunction. 10 Therefore, optimally one would include a measure of ventricular stiffness in the assessment of diastolic function in addition to the more conventional assessments of early active relaxation and filling pressures.
The ability to assess for the development of increased ventricular diastolic stiffness has the potential to (1) improve clinicians' ability to understand the natural history of the varied disease processes encountered in the pediatric heart transplantation population, (2) detect the results of therapies aimed at rejection and myocardial remodeling, and (3) improve risk stratification before interventional and surgical procedures. However, no studies have validated potential echocardiographic measures of ventricular stiffness against the goldstandard PVL measures. Therefore, the goal of this study was to assess the validity of noninvasive indices of ventricular stiffness by direct comparison with gold-standard indices derived from PVL analysis in children who have undergone heart transplantation. We hypothesized that noninvasive estimates of filling pressure divided by end-diastolic volume (EDV) would correlate well with the invasive PVL-derived ventricular stiffness constant.
METHODS
Children aged 0 to 21 years undergoing clinically indicated diagnostic left heart catheterization were recruited prospectively at a single institution. We divided our cohort into two groups. The first group included children who had undergone heart transplantation. The second group included children who acted as ''control subjects.'' Because normal children do not undergo routine heart catheterization, these children included those with hemodynamically insignificant patent ductus arteriosus or coronary fistula (Qp:Qs < 1.5 with normal LV EDV for body size). Exclusion criteria included (1) medical status for which participation in the study presented more than minimal risk as determined by the attending physician, (2) non-sinus rhythm, (3)right-sided heart disease, and (4) rejection episode (biopsy grade $ 2R, pathologic antibody-mediated rejection $ 2, or clinical or echocardiographic changes consistent with rejection that were accompanied by an augmentation in immunosuppression) within the past 6 months, as these patients were deemed at too high risk to participate in the procedures involved in the protocol. The protocol was approved by our institutional review board. Informed consent was obtained from the parents or legal guardians of minors or from participants aged $ 18 years.
Study Catheterization and PVL Analysis Protocol
All patients underwent general anesthesia per the institution's protocol. All study data were collected following the patient's primary diagnostic and interventional procedures. A 4-Fr high-fidelity microconductance catheter (CD Leycom, Hengelo, the Netherlands) was calibrated in normal saline for 15 sec and then placed in the apex of the left ventricle via the femoral arterial approach. PVLs were volume-calibrated using hypertonic saline to account for parallel conductance. Cardiac output was determined by thermodilution. Conductance electrodes located outside the ventricle were excluded from analysis. Microconductance data were recorded at a sampling rate of 250 Hz. PVL data were recorded in triplicate over 10 sec during an expiratory breath hold. Invasive data were obtained using standard equipment approved for use in human subjects (INCA intracardiac analyzer; CD Leycom). PVL analysis was performed offline using specialized software (LabChart version 8; ADInstruments, Colorado Springs, CO).
The end-diastolic pressure-volume relationship was obtained via balloon occlusion of the venae cavae and fitted to the equation ae bEDV , where b is the chamber stiffness constant, and a is the curve fitting constant. b represents the rightward, exponential aspect of the slope of the end-diastolic pressure-volume relationship and increases as ventricular stiffness increases. Increased ventricular stiffness is considered present if b > 0.015 mL À1 in adults, but abnormal stiffness has not been defined in the pediatric population, because of the lack of data in children. 14, 15 In this pilot study, we used the adult cutoff value and indexed b to body surface area to account for differences in body sizes. Early active relaxation was evaluated using the isovolumic relaxation time constant (t), calculated using the logistic method. 16 End-diastolic pressure (EDP) was recorded. End-systolic elastance (Ees), a measure of contractility, was assessed as the slope as the end-systolic pressure-volume relationship as we have previously described in this population. 17 Arterial elastance (Ea), a measure of afterload, was assessed as the ratio of end-systolic pressure to stroke volume. Ventriculoarterial coupling was calculated as Ea:Ees.
Echocardiographic Protocol
Echocardiograms were obtained immediately after PVL analysis under the same anesthetic conditions using a Phillips iE33 system (Philips, Amsterdam, the Netherlands). Ventricular volumes were derived from three-dimensional (3D) echocardiography (QLAB version 10.0; Philips). Three-dimensional echocardiographic volumes were stitched together after four-beat acquisition. Conventional echocardiographic measures of diastolic function included spectral Doppler E-and A-wave velocities and their respective ratio, E deceleration time, A-wave duration, tissue Doppler e 0 and a 0 and their respective ratios, tissue Doppler-derived isovolumic relaxation time, and pulmonary vein a-wave velocity and duration. Measurement methods conformed to recommendations by the American Society of Echocardiography and were averaged over three beats. 18 Two-dimensional speckle-tracking measures of deformation were obtained by tracing the endocardial border of the left ventricle using Cardiac Performance Analysis version 3.0 (TomTec Imaging Systems, Chicago, IL). Analysis was performed on Digital Imaging and Communications in Medicine images at their native frame rate. The minimum frame rate for acquisition was 60 frames/sec. The mean frame rate for the analyzed studies was 94 6 11 frames/sec. Longitudinal early diastolic strain rate (LEDSR) was obtained by averaging six segments from the apical four-chamber view. Circumferential early diastolic strain rate (CEDSR) was obtained by averaging six segments from the parasternal short-axis view. Studies where more than two segments could not be adequately traced were excluded.
Echocardiographic Measures of Stiffness
Assessment of the end-diastolic pressure-volume relationship and calculation of the ventricular stiffness constant can only be done by acutely altering loading conditions. This is not feasible in a noninvasive evaluation. To assess stiffness by echocardiography, we assessed operating stiffness. Conceptually, operating ventricular stiffness is described as the relationship between ventricular EDP and EDV in a patient's baseline physiologic state. 19 If one assumes that the LV volume is 0 mL when LV pressure reaches 0 mm Hg, one can calculate operating stiffness by simply dividing EDP by EDV. As b increases, operating stiffness also increases. This is conceptually displayed in Figure 1 . We used echocardiographic surrogates of EDP divided by EDV derived from 3D echocardiography to assess ventricular stiffness. Surrogates of LV EDP included lateral E:e 0 , septal E:e 0 , E:LEDSR, and E:CEDSR. 20 Therefore, the novel echocardiographic estimates of LV operating stiffness included lateral and septal E:e 0 /EDV and their average, E:LEDSR/EDV, and E:CEDSR/EDV.
Statistical Analysis
The distribution of data as parametric or nonparametric was assessed using the Shapiro-Wilk test. Differences between patient groups were assessed using independent t tests or Mann-Whitney U tests, as appropriate, for continuous variables and c 2 tests or Fisher exact tests for categorical variables. The relationship between invasive and echocardiographic measures were assessed using Pearson correlation. Receiver operating characteristic curves were created, and the area under the curve was determined to assess the discriminatory ability of each echocardiographic variable to predict the presence of increased ventricular stiffness. All studies were reassessed for intra-and interobserver variability using intraclass correlation coefficients for absolute agreement. P values < .05 were considered to indicate statistical significance. Statistical analysis were performed using SPSS version 23 (IBM, Armonk, NY).
RESULTS
A total of 24 patients were enrolled; 18 patients were status post orthotopic heart transplantation, five patients had hemodynamically insignificant patent ductus arteriosus, and one had a hemodynamically insignificant coronary fistula (six control patients). We have previously reported associations between PVL and echocardiographic measures of contractility in this cohort. 17 All control patients had successful interventions before PVL and echocardiographic acquisition. A representative PVL during preload reduction and the resulting end-diastolic pressure-volume relationship is shown in Figure 2 . Intra-and interobserver variability showed intraclass correlation coefficients of r = 0.91 and r = 0.88, respectively, for lateral E:e 0 /EDV; r = 0.92 and r = 0.86, respectively, for septal E:e 0 /EDV; r = 0.80 and r = 0.72, respectively, for E:LEDSR/EDV; and r = 0.71 and r = 0.59, respectively, for E:CEDSR/EDV.
Transplantation versus Control Patients
Demographic, clinical, and catheterization data from these patients are presented in Table 1 . There were no differences in EDP between groups. However, transplantation patients did have higher LV stiffness compared with control subjects. Echocardiographic data comparing the two groups are presented in Table 2 . Transplantation patients had higher LV mass/volume Z scores, lateral E:e 0 /EDV, and septal E:e 0 /EDV compared with control subjects. There were no differences in E:LEDSR/EDV or E:CEDSR/EDV between groups. In all patients, b displayed a correlation with Ea (r = 0.50, P = .01).
Transplantation Patients with Normal versus Abnormal Stiffness
Of 18 transplantation patients, nine (50%) had increased LV stiffness (i.e., b > 0.015 mL
À1
). Patients with increased LV stiffness were younger (5.6 6 3.2 vs 13.4 6 5.3 years, P < .01) and had lower body surface area (0.6 6 0.1 vs 1.3 6 0.4 m 2 , P < .01) than patients with normal LV stiffness. These patients also had histories of longer ischemic time (288 6 38 vs 234 6 46 min, P = .02). There were no differences in the presence of single ventricle before transplantation, history of Norwood arch reconstruction, history of rejection, or graft age between these groups. No patients displayed coronary vasculopathy.
During catheterization, there were no differences in blood pressure, mixed venous oxygen saturation, pulmonary vascular resistance, EDP, Ees, or Ea/Ees between patients with and without abnormal stiffness. Patients with elevated stiffness had a lower cardiac index (2.8 6 0.8 vs 4.2 6 0.6 L/min/m 2 , P < .01), higher Ea (3.0 6 0.7 vs 1.9 6 0.8 mm Hg/mL, P = .01), and lower t By echocardiography, patients with abnormal stiffness had lower LV EDV (37 6 10 vs 77 6 28 mL, P < .01), higher lateral E:e 0 / EDV (0.23 6 0.08 vs 0.11 6 0.05 mL À1 , P < .01), septal E:e 0 /EDV (0.32 6 0.12 vs 0.17 6 0.08 mL À1 , P < .01), and E:CEDSR/EDV (1.2 6 0.5 vs 0.6 6 0.3 cm/sec 2 /mL, P = .02) compared with patients with normal stiffness. No differences were detected in ejection fraction, shortening fraction, LV mass/volume Z score, or other Doppler or tissue Doppler measures of diastolic function.
Echocardiographic versus Invasive Measures of Diastolic Function
Lateral E:e 0 /EDV correlated well with b (r = 0.59, P < .01; Figure 3) . b also correlated with septal E:e 0 /EDV (r = 0.59, P < .01) and average E:e 0 /EDV (r = 0.57, P < .01). E:CEDSR/EDV correlated slightly less strongly with b (r = 0.54, P < .01), while E:LEDSR did not display a correlation (r = 0.28, P = . 19) . No other echocardiographic measures of diastolic function correlated with b. Correlations were similar when only transplantation patients were included in the analysis (n = 18):
HIGHLIGHTS
The objective was to validate echocardiographic measures of left ventricular stiffness. Noninvasive and invasive estimations of stiffness correlated well in children. These measures appear promising and merit further study in children.
lateral E:e 0 /EDV (r = 0.57, P < .01), septal E:e 0 /EDV (r = 0.57, P < .01), and E:CEDSR/EDV (r = 0.51, P < .01). To assess lateral E:e 0 /EDV as a measure of operating stiffness we assessed its correlation with the ratio of invasive PVL-derived EDP/EDV and found a strong correlation (r = 0.87, P < .01).
Receiver operating characteristic analysis was performed to determine each echocardiographic variable's discriminatory ability to detect an abnormal b of >0.015 mL
À1
. The area under the curve for lateral E:e 0 /EDV was 0.93 (P < .01). A lateral E:e 0 /EDV cutoff value of >0.15 mL À1 would have 89% sensitivity and 93% specificity in detecting abnormal b. The areas under the curves for septal and average E:e 0 /EDV were 0.91 (P < .01). The area under the curves for E:LEDSR/EDV and E:CESDR/EDV were 0.75 and 0.89, respectively (P < .01 for both).
Echocardiographic variables that showed statistically significant correlations to EDP or t are reported in Appendix Table 1 (available at www.onlinejase.com). Importantly, both lateral E:e 0 (r = 0.55, P < .01) and septal E:e 0 (r = 0.47, P = .02) correlated with EDP, while E:LEDSR and E:CEDSR did not.
DISCUSSION
To our knowledge, this is the first study to evaluate the relationship of echocardiographic versus invasive measures of ventricular stiffness using true gold-standard methods for PVL acquisition in pediatric heart transplant recipients. The main finding of this pilot study is that tissue Doppler E:e 0 divided by 3D echocardiographic EDV has the potential to allow a simple noninvasive assessment of LV stiffness.
Echocardiographic Evaluation of Diastolic Function
The assessment of diastolic function by echocardiography has been focused on the detection of abnormal filling pressures. However, because filling pressures are load dependent, patients may have abnormal ventricular stiffness yet normal filling pressures due to a left shift on the diastolic pressure-volume relationship secondary to autoregulatory mechanisms or through the use of diuretics. This leads to underestimation of disease severity when risk-stratifying patients. 21 By accounting for preload by indexing E:e 0 to EDV, we were able to accurately detect abnormal myocardial stiffness in pediatric heart transplant recipients, only two of whom displayed EDP > 12 mm Hg.
The results of this study are in line with a similar study by Kasner et al. 22 in adults with heart failure with preserved ejection fraction. Similar to that previous study, we found only a modest correlation between invasive and echocardiographic measures of LV stiffness. This is likely due to a number of factors. First, agreement between the two measures was not being assessed; that is, the invasive and noninvasive measures were not using the same methods to assess stiffness. The invasive measure assessed the exponential slope of the right side of the end-diastolic pressure-volume relationship, while the noninvasive measure evaluated an estimate of operational stiffness. Therefore, the resultant correlation may not be expected to be very strong. In contrast, when we compared invasive operational stiffness with noninvasive operational stiffness, we observed a strong correlation as expected when measuring agreement. Currently, a reliable noninvasive method to evaluate the end-diastolic pressure-volume relationship without load alteration does not exist. Some have attempted to validate invasive single-beat (do not require load alteration) estimates of the end-diastolic pressure-volume relationship in human ex vivo hearts. 23 However, in vivo validation, and translation to noninvasive methods, has not yet been performed.
Second, in general, the patients we assessed were relatively healthy; only two had EDP > 12 mm Hg. This may also account for the somewhat wide spread in overlap in b values for a specific E:e 0 /EDV value. It is feasible that if our patients had a wider range of stiffness, the correlations would be better. Despite the modest correlations between the PVL and echocardiographic measures of stiffness and the limitations of this study, it is important to note that E:e 0 /EDV was the only echocardiographic measure of diastolic function to have a correlation with b. All conventional measures of diastolic function, including late measures (Doppler A, tissue Doppler a 0 , A/a 0 , etc) had no correlation with b. In addition, lateral E:e 0 /EDV had a high area under the curve for detecting abnormal b. Therefore, in this pilot study, E:e 0 /EDV appeared to be the only echocardiographic measure to have some promise of assessing ventricular stiffness in pediatric heart transplant recipients and merits further validation studies to assess its accuracy and clinical utility.
We defined abnormal stiffness as b > 0.015 mL
À1
. It is important to note this value has not been validated in children. To make this cutoff value more applicable to children, we indexed b to BSA to account for differences in body sizes between adults and children. In addition, there is some evidence that the cutoff value may be useful as we found that those patients with b Â BSA > 0.015 had histories of longer ischemic time, lower cardiac index, and higher afterload. These are all known predictors of stiffness after transplantation in the adult population. However, we recognize that the actual cutoff value for abnormal stiffness may be different in children, which would perhaps make the cutoff values for E:e 0 /EDV suggested in this study less accurate.
Potential Clinical Uses of E:e 0 /EDV
The ability to noninvasively detect abnormal ventricular stiffness before elevation of EDP has multiple potential clinical uses that merit further study. It may possibly be used to predict the cardiac response to exercise and patient functional status, especially in children, who often cannot undergo formal exercise testing and have poor communication skills. 15 In addition, the assessment of ventricular stiffness has the potential to be used to detect acute rejection and resultant myocardial recovery. 3, 24 Its strengths lie in the facts that it is a simple measure to make, the individual measures are reproducible in children, 25 the limitations of tissue Doppler and 3D echocardiography are well studied, 18 and many echocardiographic laboratories already use these technologies, making translation to clinical practice highly feasible.
The validation of this noninvasive measure of ventricular stiffness has the potential to provide important insights into disease progression and response to treatment in other patient populations, such as those with congenital heart disease, a population of patients who spend their entire lifetimes exposed to abnormal loading conditions that predispose them to myocardial fibrosis and resulting decreased ventricular compliance. The validity of E:e 0 /EDV as a measure of stiffness in other populations is conceptually valid. However, to be applicable in the broader congenital heart disease population, these measures must be independently validated in these separate populations. In addition, normative values will need to be established in children.
Pediatric Transplant Patients with Increased Ventricular Stiffness
We detected a high rate of increased ventricular stiffness in the pediatric heart transplantation sample (50%). Patients with increased stiffness had increased ischemic time compared with those with normal stiffness. This is in line with what has been reported previously and with reports of the association ischemic time with myocardial fibrosis development. [26] [27] [28] In addition, patients with increased stiffness also displayed elevated afterload. Elevated afterload is known to contribute to the development of abnormal stiffness and increased filling pressures, in line with the correlation we found between b and Ea. 29 Patients with increased stiffness were also younger. Because of the small sample size, we are unable to determine if patient age is an independent predictor of stiffness in this study, as there are many confounders that may contribute to this finding, such as ischemic time, graft age, afterload, donor-recipient size mismatch, and so on. This finding indeed requires further study. The detection of worsening stiffness noninvasively using E:e 0 /EDV may be useful to clinicians in decision making regarding antihypertensive therapies. Previous studies have found that history of rejection, graft age, and donor-recipient size mismatch contribute to diastolic dysfunction in heart transplant recipients. 1 We did not detect differences in these measures between groups, likely because of our small sample size.
Limitations
As is often the case in invasive pediatric studies, one of the limiting factors in interpreting the results is a small study sample. These results should ideally be validated in a larger sample. The control group was not derived from healthy children, as healthy children do not undergo catheterization. However, control patients had cardiac lesions that were hemodynamically insignificant and should not have influenced ventricular stiffness. We may not have detected important differences between the transplantation and control group because of inadequate power. We could not perform regression analysis to detect independent predictors of increased ventricular stiffness because of the small sample size. The sensitivity and specificity derived from receiver operating curve analysis is a ''best-case scenario,'' as these values were not confirmed in a validation cohort. As noted above, the results of this study are not necessarily applicable to other disease states. For example, in patients with normal early relaxation but abnormal stiffness, E:e 0 may not be associated with filling pressures; therefore, E:e 0 /EDV would not be an appropriate measure of operational stiffness. Therefore, further studies in different patient groups to validate this method are warranted.
CONCLUSIONS
An echocardiographic measure of operating stiffness, the E:e 0 /EDV ratio, correlated well with the reference standard measure of LV stiffness derived from PVL analysis. E:e 0 /EDV appeared to be accurate in detecting pediatric heart transplant recipients with abnormal ventricular stiffness. This noninvasive measure of ventricular stiffness may allow us to gain new insights into the physiology and natural history of pediatric heart transplant patients, detect changes in ventricular stiffness after medical interventions, and allow the opportunity investigate the relationship of ventricular stiffness to patient outcomes.
